. Author manuscript; available in PMC: 2010 Feb 1.

Published in final edited form as: Invest Ophthalmol Vis Sci. 2008 Oct 20;50(2):674–680. doi: 10.1167/iovs.08-1767

TABLE 1.

Findings for the OH/EG and Normal Subjects

Variable	OH/EG	Normals
Sex, female/male	96/72	63/37
Age, y (mean ± SD)	58.2 ± 11.1	48.8 ± 13.6
IOP, mm Hg (mean ± SD)^*	19.7 ± 3.9	14.6 ± 2.7
CCT, µm (mean ± SD)^†	557 ± 38	NA
MD, dB (mean ± SD)	−0.18 ± 2.3	+0.85 ± 1.1
PSD, dB (mean ± SD)	2.51 ± 1.7	1.55 ± 0.4
PSD ONL, (% eyes)	16.7	0.5
GHT ONL, (% eyes)	27.4	2.5
Cluster, (% eyes)^‡	23.5	1.0
VF ONL, (% eyes)	34.8	3.0
bGON, (% eyes)	57.1	0.0
pGON, (% eyes)	27.7	NA
Glaucoma, (% subjects)	87.5	6.0

ONL, outside normal limits; bGON, baseline glaucomatous optic neuropathy; pGON, progressive glaucomatous optic neuropathy.

Measurement missing for both eyes of three OH/EG individuals and three normals.

^†

Measure missing for both eyes of 20 OH/EG individuals and for all normals.

^‡

Clusters were confined to a single hemifield and consisted of at least three locations at or below P < 0.05, one of which was at or below P < 0.01 level.